FUM vs. SBTX, SAR, AREC, COS, C4XD, DDDD, POLB, OKYO, AOR, and APTA
Should you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include SkinBioTherapeutics (SBTX), Sareum (SAR), Arecor Therapeutics (AREC), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Poolbeg Pharma (POLB), OKYO Pharma (OKYO), AorTech International (AOR), and Aptamer Group (APTA). These companies are all part of the "biotechnology" industry.
Futura Medical vs. Its Competitors
SkinBioTherapeutics (LON:SBTX) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.
In the previous week, SkinBioTherapeutics' average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.
SkinBioTherapeutics has higher earnings, but lower revenue than Futura Medical. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.
Futura Medical has a net margin of -44.64% compared to SkinBioTherapeutics' net margin of -237.95%. Futura Medical's return on equity of -56.44% beat SkinBioTherapeutics' return on equity.
SkinBioTherapeutics has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.
3.4% of SkinBioTherapeutics shares are owned by institutional investors. Comparatively, 0.0% of Futura Medical shares are owned by institutional investors. 2.7% of SkinBioTherapeutics shares are owned by company insiders. Comparatively, 1.5% of Futura Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
SkinBioTherapeutics beats Futura Medical on 6 of the 11 factors compared between the two stocks.
Get Futura Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Futura Medical Competitors List
Related Companies and Tools
This page (LON:FUM) was last updated on 10/10/2025 by MarketBeat.com Staff
